SCHEMBL10467804

SCHEMBL10467804

CCOC(=O)C(/C=N\O)C(C)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GLO1 Q04760 1/20 0.35
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HPGD P15428 2/20 0.33
ALOX15 P16050 1/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
SOAT1 P35610 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
MAPT P10636 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10425662 0.90 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10GLO1CYP2D6
SCHEMBL17984614 0.79 ALDH1A1 (0.41) ALDH1A1LMNAHSD17B10HPGDALOX15
SCHEMBL6070239 0.77 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10GLO1CYP2D6
SCHEMBL15046951 0.75 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10GLO1CYP2D6
SCHEMBL2307304 0.73 ALDH1A1 (0.37) ALDH1A1LMNAHSD17B10GLO1CYP2D6
SCHEMBL642855 0.73 CYP2D6 (0.46) ALDH1A1LMNAHSD17B10GLO1CYP2D6
SCHEMBL4900324 0.73 MEN1 (0.49) ALDH1A1LMNAGAAMAPTUSP2
SCHEMBL11461030 0.72 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GLO1CYP2D6
SCHEMBL31208165 0.72 ALDH1A1 (0.36) ALDH1A1LMNAHSD17B10GLO1CYP2D6
SCHEMBL28116044 0.72 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GLO1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160237059-A1 HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-08-18 US disclosed
US-4929738-A BACTERICIDES, FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 1990-05-29 US disclosed
US-4864029-A MICROBIOCIDE INTERMEDIATES BAYER AKTIENGESELLSCHAFT (DE) 1989-09-05 US disclosed
US-4767775-A Substituted pyrazolin-5-ones, composition containing them, and method of combating fungi or bacteria BAYER AKTIENGESELLSCHAFT (DE) 1988-08-30 US disclosed
US-4598147-A THIAZOLE INTERMEDIATES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160237059-A1 HETEROCYCLIC SUBSTITUTED TRIFLUOROMETHYL PYRIMIDINONES AND THEIR USE REN, GLS, FIBP ALDH1A1 1089/4885LMNA 604/4885HSD17B10 4092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.